ROME Therapeutics is developing novel therapies for autoimmunity, cancer, neurodegeneration, and age-related diseases by deciphering the biological functions of the repeatome, which encompasses vast numbers of genetic elements encoded within the “dark genome”. With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled ...
